Antisense oligonucleotides are now entering the clinic for hard-to-treat diseases. New chemical modifications are urgently required to enhance their drug-like properties. We combine amide coupling with standard oligonucleotide synthesis to assemble backbone chimera gapmers that trigger an efficient RNase H response while improving serum life time and cellular uptake.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/d0cc00444h | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!